146 related articles for article (PubMed ID: 12377863)
1. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy.
Frustaci A; Calabrese F; Chimenti C; Pieroni M; Thiene G; Maseri A
Chest; 2002 Oct; 122(4):1348-56. PubMed ID: 12377863
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.
Frustaci A; Chimenti C; Calabrese F; Pieroni M; Thiene G; Maseri A
Circulation; 2003 Feb; 107(6):857-63. PubMed ID: 12591756
[TBL] [Abstract][Full Text] [Related]
3. Histologically proven myocarditis in patients with biventricular dysfunction and severe asymptomatic coronary artery disease.
Chimenti C; Frustaci A; Pieroni M; Maseri A
Cardiologia; 1999 Feb; 44(2):177-80. PubMed ID: 10208054
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy.
Matsumori A; Yutani C; Ikeda Y; Kawai S; Sasayama S
Lab Invest; 2000 Jul; 80(7):1137-42. PubMed ID: 10908160
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.
Escher F; Kühl U; Lassner D; Poller W; Westermann D; Pieske B; Tschöpe C; Schultheiss HP
Clin Res Cardiol; 2016 Dec; 105(12):1011-1020. PubMed ID: 27312326
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive treatment of chronic non-viral myocarditis.
Frustaci A; Pieroni M; Chimenti C
Ernst Schering Res Found Workshop; 2006; (55):343-51. PubMed ID: 16329671
[TBL] [Abstract][Full Text] [Related]
7. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
8. Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis.
Frustaci A; Chimenti C; Maseri A
Circulation; 1999 Mar; 99(10):1295-9. PubMed ID: 10077512
[TBL] [Abstract][Full Text] [Related]
9. Chronic variant of myocarditis associated with hepatitis C virus infection.
Okabe M; Fukuda K; Arakawa K; Kikuchi M
Circulation; 1997 Jul; 96(1):22-4. PubMed ID: 9236410
[TBL] [Abstract][Full Text] [Related]
10. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
[TBL] [Abstract][Full Text] [Related]
11. [Efficiency of immunosuppressive therapy in virus-negative and virus-positive patients with morphologically verified lymphocytic myocarditis].
Blagova OV; Nedostup AV; Kogan EA; Sulimov VA
Ter Arkh; 2017; 89(8):57-67. PubMed ID: 28914852
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy of biopsy proved immune-mediated lymphocytic myocarditis in the virus-negative and virus-positive patients.
Blagova O; Nedostup A; Kogan E; Zaitsev A; Fomin V
Cardiovasc Pathol; 2020; 49():107260. PubMed ID: 32683240
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis.
Narula J; Khaw BA; Dec GW; Palacios IF; Newell JB; Southern JF; Fallon JT; Strauss HW; Haber E; Yasuda T
J Nucl Cardiol; 1996; 3(5):371-81. PubMed ID: 8902668
[TBL] [Abstract][Full Text] [Related]
14. The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention.
Elsanhoury A; Kühl U; Stautner B; Klein O; Krannich A; Morris D; Willner M; Jankowska E; Klingel K; Van Linthout S; Tschöpe C
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215893
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
16. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis.
Camargo PR; Snitcowsky R; da Luz PL; Mazzieri R; Higuchi ML; Rati M; Stolf N; Ebaid M; Pileggi F
Pediatr Cardiol; 1995; 16(2):61-8. PubMed ID: 7784236
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy in myocarditis.
Frustaci A; Chimenti C
Circ J; 2015; 79(1):4-7. PubMed ID: 25452202
[TBL] [Abstract][Full Text] [Related]
18. Dilated cardiomyopathy associated with hepatitis C virus infection.
Matsumori A; Matoba Y; Sasayama S
Circulation; 1995 Nov; 92(9):2519-25. PubMed ID: 7586353
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and cardiomyopathy.
Matsumori A
Herz; 2000 May; 25(3):249-54. PubMed ID: 10904847
[TBL] [Abstract][Full Text] [Related]
20. Newer aspects of pathogenesis of heart failure: hepatitis C virus infection in myocarditis and cardiomyopathy.
Matsumori A; Sasayama S
J Card Fail; 1996 Dec; 2(4 Suppl):S187-94. PubMed ID: 8951578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
